Literature DB >> 15031000

Ethanol regulation of gamma-aminobutyric acid A receptors: genomic and nongenomic mechanisms.

Sandeep Kumar1, Rebekah L Fleming, A Leslie Morrow.   

Abstract

gamma-Aminobutyric acid(A) (GABA(A)) receptors are ligand-gated ion channels that, predominantly, mediate inhibitory synaptic transmission in the CNS. These receptors are pentameric complexes that are comprised of subunits from several classes (alpha, beta, gamma, delta, ), with each class consisting of several isoforms. Chronic ethanol consumption alters GABA(A) receptor function producing cellular tolerance to GABA and ethanol, cross-tolerance to benzodiazepines and barbiturates, and sensitization to inverse agonists. Recent studies have clearly demonstrated that GABA(A) receptors play an important role in ethanol dependence and functional properties of GABA(A) receptor are altered following chronic ethanol administration. However, the exact mechanisms that account for alterations in GABA(A) receptor function following chronic ethanol administration have not been resolved. The mechanisms responsible for adaptation of GABA(A) receptors to chronic ethanol exposure may involve ethanol-induced changes in cell surface expression, subcellular localization, synaptic localization, receptor phosphorylation, neurosteroids, and/or changes in GABA(A) receptor subunit composition. In this review, we provide an overview of recent data pertaining to mechanisms that could be responsible for altered properties and expression of GABA(A) receptors following chronic ethanol administration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031000     DOI: 10.1016/j.pharmthera.2003.12.001

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  63 in total

Review 1.  Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

Authors:  Kelly P Cosgrove; Irina Esterlis; Graeme F Mason; Frederic Bois; Stephanie S O'Malley; John H Krystal
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

2.  Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release.

Authors:  Vladimir Chefer; Jennifer Meis; Grace Wang; Alexander Kuzmin; Georgy Bakalkin; Toni Shippenberg
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

3.  Mechanisms of reversible GABAA receptor plasticity after ethanol intoxication.

Authors:  Jing Liang; Asha Suryanarayanan; Alana Abriam; Bradley Snyder; Richard W Olsen; Igor Spigelman
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 4.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

5.  Dancing the delta shuffle: neurosteroids regulate GABAA receptor expression.

Authors:  Andre Lagrange
Journal:  Epilepsy Curr       Date:  2006 Jan-Feb       Impact factor: 7.500

6.  Racial variations in the incidence of severe alcohol withdrawal.

Authors:  Gar Ming Chan; Robert S Hoffman; Jeffrey A Gold; Paula J Whiteman; Lewis R Goldfrank; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2009-03

7.  Plasticity of GABAA receptors in brains of rats treated with chronic intermittent ethanol.

Authors:  Richard W Olsen; Jing Liang; Elisabetta Cagetti; Igor Spigelman
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 8.  GABAA receptor: Positive and negative allosteric modulators.

Authors:  Richard W Olsen
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

Review 9.  Mechanisms of ethanol-induced degeneration in the developing, mature, and aging cerebellum.

Authors:  Pia Jaatinen; Jyrki Rintala
Journal:  Cerebellum       Date:  2008-04-12       Impact factor: 3.847

Review 10.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.